-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Coya Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2021 to Q3 2025.
- Coya Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$2.12M, a 47.4% increase year-over-year.
- Coya Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$18.4M, a 72.3% decline year-over-year.
- Coya Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$14.9M, a 86.3% decline from 2023.
- Coya Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.99M, a 34.8% increase from 2022.
- Coya Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$12.2M, a 150% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)